From: Peripheral blood gene expression profiles in COPD subjects
Phenotype | Case ID | Array ID | Age | Race | Gender | FEV1 %Pred | FVC %Pred | FEV1/FVC | Diagnosis |
---|---|---|---|---|---|---|---|---|---|
Case 1 | 2797 | 987W | 70 | Caucasian | Male | 25.22 | 37 | 56 | NSC Squamous |
Case 2 | 3589 | 987I | 59 | Caucasian | Female | 28.12 | 52 | 44 | NSC Squamous |
Case 3 | 2224 | 987H | 52 | Caucasian | Female | 31.10 | 46 | 52 | NSC |
Case 4 | 1576 | 987U | 68 | Caucasian | Male | 36.29 | 75 | 43 | Emphysema |
Case 5 | 3660 | 987K | 77 | Caucasian | Male | 43.34 | 75 | 53 | NSC Squamous |
Case 6 | 2267 | 987N | 56 | Caucasian | Male | 46.58 | 67 | 56 | NSC Squamous |
Case 7 | 3175 | 987B | 75 | Caucasian | Male | 47.59 | 94 | 41 | NSC Adeno |
Case 8 | 3043 | 987A | 61 | Caucasian | Male | 52.12 | 81 | 59 | NSC Squamous |
Case 9 | 2336 | 987M | 65 | African-American | Female | 65.66* | 99 | 51 | NSC Adeno |
Case 10 | 2195 | 987E | 53 | Caucasian | Female | 60.36 | 88 | 57 | NSC Adeno |
Case 11 | 2195 | 987F | 53 | Caucasian | Female | 60.36 | 88 | 57 | NSC Adeno |
Case 12 | 3822 | 987R | 64 | Caucasian | Male | 66.81 | 94 | 54 | NSC Squamous |
Average | Â | Â | 62.75 | Â | Â | 45.26 | 74.67 | 51.92 | Â |
Control 1 | 1769 | 987X | 50 | Caucasian | Female | 82.69 | 119 | 75 | NSC Adeno |
Control 2 | 2563 | 987T | 55 | Caucasian | Female | 87.07 | 95 | 76 | NSC Adeno |
Control 3 | 3712 | 987Q | 62 | Caucasian | Female | 87.12 | 80 | 86 | NSC Squamous |
Control 4 | 2473 | 987S | 77 | Caucasian | Female | 91.53 | 81 | 82 | NSC Squamous |
Control 5 | 2254 | 987J | 71 | Caucasian | Female | 95.00 | 94 | 78 | NSC Adeno |
Control 6 | 3761 | 987O | 40 | Caucasian | Male | 95.37 | 101 | 82 | Carcinoid |
Control 7 | 3143 | 987C | 71 | Caucasian | Male | 103.28 | 115 | 72 | NSC Adeno |
Control 8 | 3708 | 987L | 78 | Caucasian | Female | 104.42 | 91 | 85 | Metastatic Renal Cell Carcinoma |
Control 9 | 3529 | 987D | 54 | Caucasian | Female | 105.15 | 116 | 75 | Unknown |
Control 10 | 3555 | 987G | 55 | Caucasian | Male | 108.49 | 118 | 79 | Inflammation |
Control 11 | 1584 | 987V | 68 | Caucasian | Female | 110.95 | 117 | 74 | NSC Adeno |
Control 12 | 3769 | 987P | 78 | Caucasian | Male | 112.01 | 117 | 78 | NSC-mixed |
Average | Â | Â | 63.25 | Â | Â | 98.59 | 103.67 | 78.5 | Â |